Tissue informative cell-free DNA methylation sites in amyotrophic lateral sclerosis
Caggiano, C.; Morselli, M.; Qian, X.; Celona, B.; Thompson, M.; Wani, S.; Tosevska, A.; Taraszka, K.; Heuer, G.; Ngo, S.; Steyn, F.; Nestor, P. J.; Wallace, L.; McCombe, P.; Heggie, S.; Thorpe, K.; McElligott, C.; English, G.; Henders, A.; Henderson, R.; Lomen-Hoerth, C.; Wray, N. R.; McRae, A. F.; Pellegrini, M.; Garton, F. C.; Zaitlen, N.
Show abstract
Cell-free DNA (cfDNA) is increasingly recognized as a promising biomarker candidate for disease monitoring. However, its utility in neurodegenerative diseases, like amyotrophic lateral sclerosis (ALS), remains underexplored. Existing biomarker discovery approaches are tailored to a specific disease context or are too expensive to be clinically practical. Here, we address these challenges through a new approach combining advances in molecular and computational technologies. First, we develop statistical tools to select tissue-informative DNA methylation sites relevant to a disease process of interest. We then employ a capture protocol to select these sites and perform targeted methylation sequencing. Multi-modal information about the DNA methylation patterns are then utilized in machine learning algorithms trained to predict disease status and disease progression. We applied our method to two independent cohorts of ALS patients and controls (n=192). Overall, we found that the targeted sites accurately predicted ALS status and replicated between cohorts. Additionally, we identified epigenetic features associated with ALS phenotypes, including disease severity. These findings highlight the potential of cfDNA as a non-invasive biomarker for ALS.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Divergent impacts of C9orf72 repeat expansion on neurons and glia in ALS and FTD 93%
- An integrative systems-biology approach defines mechanisms of Alzheimer's disease neurodegeneration 93%
- A meta-analysis of epigenome-wide association studies in Alzheimer's disease highlights novel differentially methylated loci across cortex 93%
Similar papers in this journal
- Diagnostic Evidence GAuge of Single cells (DEGAS): A flexible deep-transfer learning framework for prioritizing cells in relation to disease 93%
- SiRCle (Signature Regulatory Clustering) model integration reveals mechanisms of phenotype regulation in renal cancer 92%
- DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas (PanNECs) and pancreatic neuroendocrine tumors (PanNETs) 91%
Similar papers in this journal
- Non-Coding and Loss-of-Function Coding Variants in TET2 are Associated with Multiple Neurodegenerative Diseases 94%
- Dystonia-specific mutations in THAP1 alter transcription of genes associated with neurodevelopment and myelin 94%
- Landscapes of missense variant impact for human superoxide dismutase 1 93%
Similar papers in this journal
- Characterising tandem repeat complexities across long-read sequencing platforms with TREAT and otter 94%
- Deciphering D4Z4 CpG methylation gradients in fascioscapulohumeral muscular dystrophy using nanopore sequencing 93%
- Transcriptional modulation unique to vulnerable motor neurons predicts ALS across species and SOD1 mutations 93%
Similar papers in this journal
- Modeling of mitochondrial genetic polymorphisms reveals induction of heteroplasmy by pleiotropic disease locus MT:10398A>G 95%
- Gene co-expression network analysis in human spinal cord highlights mechanisms underlying amyotrophic lateral sclerosis susceptibility 94%
- Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.